Newsfeeds - Spark Newswire

3 minute read

Maravai LifeSciences Announces CEO Leadership Transition

Today, 2:13 PM

Maravai LifeSciences, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that its Board of Directors has appointed William

MRVI

5 minute read

Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:13 PM

Gainers

ACB

2 minute read

News

TriLink BioTechnologies, Part Of Maravai LifeSciences, Expands Its mRNA Raw Material Offering With The First GMP-grade Modified Nucleoside-Triphosphate Product

By Benzinga Newsdesk

Today, 2:13 PM

TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (Maravai) (NASDAQ:MRVI) and global provider of life science reagents and services, has expanded its GMP-grade product offering to include

MRVI

28 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 2:13 PM

On Thursday, 529 companies set new 52-week lows.

$APE

15 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 2:13 PM

On Monday, 273 companies set new 52-week lows.

ABT

8 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 2:13 PM

During Friday's session, 132 stocks hit new 52-week lows.

AGFY

14 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 25, 2022

By Benzinga Insights

Today, 2:13 PM

Upgrades

1 minute read

Maravai LifeSciences Lowers FY2022 Adj EPS Guidance from $1.74-1.90 to $1.70-1.80; Lowers FY2022 Sales Guidance from $920.00M-960.00M to $880.00M-910.00M

By Benzinga Newsdesk

Today, 2:13 PM

Maravai LifeSciences (NASDAQ:MRVI) lowers FY2022 Adj EPS guidance from $1.74-1.90 to $1.70-1.80. Lowers FY2022 sales outlook from $920.00 million-960.00 million to $880.00 million-910.00 million.

MRVI